ENT Biotech Solutions

Detroit, United States Founded: 2011 • Age: 15 yrs
A disposable, single-use tool that cuts, cauterizes and removes tissue during tonsil and adenoid surgery

About ENT Biotech Solutions

ENT Biotech Solutions is a company based in Detroit (United States) founded in 2011.. ENT Biotech Solutions has raised $2.04 million across 2 funding rounds from investors including Michigan Economic Development. ENT Biotech Solutions operates in a competitive market with competitors including Protip Medical, Chemo Mouthpiece, APrevent, OTT Medical and Surgimed, among others.

  • Headquarter Detroit, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.04 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.1 M (USD), Series A

    Apr 25, 2016

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ENT Biotech Solutions

ENT Biotech Solutions has successfully raised a total of $2.04M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.1 million completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $1.1M
  • First Round

    (14 Jul 2014)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2016 Amount Series A - ENT Biotech Solutions Valuation

investors

Jul, 2014 Amount Seed - ENT Biotech Solutions Valuation Michigan Economic Development
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ENT Biotech Solutions

ENT Biotech Solutions has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Michigan Economic Development. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Economic development in Michigan is advanced by the foundation.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ENT Biotech Solutions

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ENT Biotech Solutions

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ent Biotech Solutions Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ENT Biotech Solutions

ENT Biotech Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Protip Medical, Chemo Mouthpiece, APrevent, OTT Medical and Surgimed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Implantable devices for larynx surgery are developed to reduce complications.
domain founded_year HQ Location
Developer of a cryotherapy device to cool the entire oral cavity
domain founded_year HQ Location
-
domain founded_year HQ Location
Offers professional architectural services for homeowners and commercial developers worldwide.
domain founded_year HQ Location
Develops innovative technologies for vocal cord nerve monitoring.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ent Biotech Solutions

Frequently Asked Questions about ENT Biotech Solutions

When was ENT Biotech Solutions founded?

ENT Biotech Solutions was founded in 2011 and raised its 1st funding round 3 years after it was founded.

Where is ENT Biotech Solutions located?

ENT Biotech Solutions is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.

Is ENT Biotech Solutions a funded company?

ENT Biotech Solutions is a funded company, having raised a total of $2.04M across 2 funding rounds to date. The company's 1st funding round was a Seed of $940K, raised on Jul 14, 2014.

What does ENT Biotech Solutions do?

ENT Biotech Solutions was founded in 2011 in Detroit, United States, within the medical device sector. Focus is placed on developing Elasso, a disposable, single-use tool designed for tonsil and adenoid procedures. Tissue is cut, cauterized, and removed in a single step during surgeries. Operations center on advancing ENT surgical tools to support clinical efficiency in the United States.

Who are the top competitors of ENT Biotech Solutions?

ENT Biotech Solutions's top competitors include Chemo Mouthpiece, Protip Medical and APrevent.

Who are ENT Biotech Solutions's investors?

ENT Biotech Solutions has 1 investor. Key investors include Michigan Economic Development.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available